1) Ahl J, Arnold LM, Clauw D, et al:Flexible dosed duloxetine in the treatment of fibromyalgia:A randomized, double-blind, placebo-controlled trial. J Rheumatol 37:2578-2586, 2010
2) American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed, 2010
3) Bird HA, Esselinckx W, Dixon AS, et al:An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434-439, 1979
4) Brown ES, Woolston DJ, Frol A, et al:Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55:538-545, 2004
5) Chuang TY, Hunder GG, Ilstrup DM, et al:Polymyalgia rheumatica:A 10-year epidemiologic and clinical study. Ann Intern Med 97:672-680, 1982
6) Healey LA:Long-term follow-up of polymyalgia rheumatica:Evidence for synovitis. Semin Arthritis Rheum 13:322-328, 1984
7) 伊井裕一郎,葛原茂樹:【精神症状からみた老年期の神経疾患】神経疾患治療薬による精神症状―副腎皮質ステロイドによる精神症状.老年精神医学雑誌15:846-850, 2004
8) Ling MHM, Perry PJ, Tsuang MT:Side effects of corticosteroid therapy. Arch Gen Psychiatry 38:471-477, 1981
9) Sato T, Wada K, Yamada N, et al:Corticosteroid-induced psychotic and mood disorders:Diagnosis defined by DSM-Ⅳ and clinical pictures. Psychosomatics 42:461-466, 2001
10) Spina E, Scordo MG, D' Arrigo C:Metabolic drug interactions with new psychotropic agents. Fundam Clin Pharmacol 17:517-538, 2003
11) Terao T, Mizuki T, Ohji T, et al:Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid. Br J Psychiatry 164:109-111, 1994
12) 渡邊尚志,今西泰一郎,角井信一,他:ミルタザピンの薬理プロファイル αアドレナリン受容体モデルによる結合様式の観点から.新薬と臨床58:1152-1160, 2009
13) Yoshimura R, Ueda N, Nakamura J:Successful treatment of steroid-induced depression with low dosage of fluvoxamine. Aust N Z J Psichiatry 35:855-856, 2001